SLU PP 332 EN: PROPRIETARY MIXTURE OF SLU PP 332

10,000 Micrograms Per Capsule. 1 Capsule of Our SLU PP 332EN Has More Active Ingredient Than an Entire Bottle of the Competing Products on the Market

SLU PP 332EN is our proprietary Estrogen Related Receptor Agonist, developed as an analogue to SLU PP 332, a compound widely recognized and often referred to as the “exercise in a pill.”

Our molecule is almost exactly the same as the SLU PP 332, comes from the same research paper and is superimposable, bioidentical, with all of the same activity, if not greater. Plus, we have added Magnesium Glycinate and Nicotinamide as fuel for the Mitochondria to work along and synergize the activity of our SLU PP compound. 

We are proud to announce that we are now producing this groundbreaking Estrogen Related Receptor Agonist, originally known as SLU PP 332, under our exclusive brand name SLU PP 332EN. The ingredient is manufactured at our FDA-registered facility in Fort Lauderdale and then encapsulated at a separate FDA facility in Hialeah using our proprietary, patent-pending blend with Nicotinamide.

Each capsule delivers 10,000 MICROGRAMS of active ingredient, combined with 200 Milligrams Nicotinamide and 200 milligrams of Magnesium Glycinate to enhance mitochondrial stimulation.

Excellent for use with GLP weight loss

How It Works  

SLU-PP-332EN activates estrogen related receptors (ERRα, ERRβ, and ERRγ), mimicking the metabolic effects of endurance exercise.

Key Benefits  

• Increases energy expenditure  

• Boosts fat metabolism without appetite suppression  

• Improves mitochondrial function  

• Enhances glucose tolerance & insulin sensitivity  

• Supports weight loss without muscle degradation  

• Potential kidney-protective benefits (per preclinical studies)

Research Backing  

SLU-PP-332EN has demonstrated endurance increases of up to 70%, reduced fat gain, and 12% body weight loss in obese mice, even with no change in activity or diet.